Availability is the metric Nigeria’s health system tends to reach for first. Are the medicines on the shelf? Is the facility stocked? These are the questions that dominate procurement conversations and supply chain assessments. They are necessary questions. They are not sufficient ones.
The harder question, the one that Toyin Opeyemi Abobade’s work consistently surfaces, is whether medicines that are technically available are actually delivering their intended outcomes for patients. That is a different problem entirely, and it is one that receives far less attention than it deserves.
Abobade is Deputy Director of Pharmaceutical Services at the Lagos State Health Service Commission, where she oversees pharmaceutical operations across multiple public health facilities in Lagos State.
Her professional focus spans pharmacovigilance, rational drug use, medication therapy management, and patient counselling, areas that collectively address the space between a medicine leaving a shelf and a patient recovering from an illness.
That space is where a significant portion of Nigeria’s pharmaceutical value is currently being lost. A medicine prescribed without adequate patient counselling has a reduced chance of being taken correctly. A drug interaction that goes undetected because adverse reaction monitoring is inconsistent can turn a treatable condition into a clinical emergency.
An essential medicine procured and stocked but distributed through an overwhelmed system without proper storage controls loses potency before it reaches the patient. These are not hypothetical scenarios. They are recurring features of underfunded, overstretched pharmaceutical systems.
What Abobade’s fifteen-year career inside the Lagos State Health Service Commission demonstrates is that solving these problems requires more than technology or procurement reform. It requires pharmacists who understand the full patient journey, from prescription through dispensing through adherence, and who are empowered to intervene at every stage of it.
Her progression from staff pharmacist to Deputy Director reflects an accumulation of exactly that understanding.
At each level, she has worked the problems that determine whether pharmaceutical care functions in practice, not in policy documents.
The conversation Nigeria’s health sector needs to have is not only about how many medicines are in the system. It is about how many of those medicines are working as intended, for which patients, and why.
Answering that question seriously requires the kind of institutional expertise that practitioners like Abobade represent. It also requires a health system willing to listen to what that expertise is saying.
The medicines are often there. The outcomes frequently are not. That gap is the real crisis, and closing it starts with taking pharmaceutical care seriously as a discipline, not just as a logistics function.
Join BusinessDay whatsapp Channel, to stay up to date
Open In Whatsapp
